S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(1.45%) $922.85
USD/EUR
(0.15%) $0.928
USD/NOK
(0.32%) $10.88
USD/GBP
(-0.01%) $0.792
USD/RUB
(-0.03%) $92.55

Realtime updates for Immunocore Holdings plc [IMCR]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
100.00%
return 6.60%
SELL
0.00%
return 9.99%
Last Updated28 Mar 2024 @ 16:00

2.23% $ 65.00

BUY 62236 min ago

@ $71.91

Issued: 14 Feb 2024 @ 15:47


Return: -9.60%


Previous signal: Feb 14 - 09:30


Previous signal: Sell


Return: -2.49 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases...

Stats
Today's Volume 356 003
Average Volume 491 452
Market Cap 3.23B
EPS $0 ( 2024-02-28 )
Next earnings date ( $-0.320 ) 2024-05-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -45.77
ATR14 $0.0720 (0.11%)
Insider Trading
Date Person Action Amount type
2024-02-28 Berman David M Sell 36 509 Employee Share Option (Right to Buy)
2024-02-28 Berman David M Buy 36 509 Ordinary Shares
2024-02-28 Berman David M Sell 16 900 Ordinary Shares
2024-02-28 Berman David M Sell 7 472 Ordinary Shares
2024-02-28 Berman David M Sell 10 937 Ordinary Shares
INSIDER POWER
-76.12
Last 60 transactions
Buy: 603 276 | Sell: 4 743 683

Volume Correlation

Long: 0.48 (neutral)
Short: 0.50 (neutral)
Signal:(73.28) Neutral

Immunocore Holdings plc Correlation

10 Most Positive Correlations
AMRB0.859
LWAC0.837
MMAC0.835
10 Most Negative Correlations
SVAC-0.83
TLGT-0.821

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Immunocore Holdings plc Correlation - Currency/Commodity

The country flag -0.42
( neutral )
The country flag -0.59
( weak negative )
The country flag 0.00
( neutral )
The country flag -0.40
( neutral )
The country flag 0.61
( weak )
The country flag 0.12
( neutral )

Immunocore Holdings plc Financials

Annual 2023
Revenue: $249.43M
Gross Profit: $248.39M (99.58 %)
EPS: $-0.00110
Q4 2023
Revenue: $105.64M
Gross Profit: $105.88M (100.23 %)
EPS: $-0.000500
Q3 2023
Revenue: $51.49M
Gross Profit: $51.27M (99.57 %)
EPS: $0.0400
Q2 2023
Revenue: $47.76M
Gross Profit: $46.88M (98.15 %)
EPS: $-0.290

Financial Reports:

No articles found.

Immunocore Holdings plc

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators